MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis

Low grade serous ovarian and peritoneal cancer (LGSC) is a rare subtype, representing 2% of all epithelial ovarian carcinomas (EOCs) [1]. Because of its rarity, very little is still known about its pathogenesis, molecular biology and, consequently, about the best applicable therapeutic strategies.

Source: Cancer Treatment Reviews - August 23, 2022 Category: Cancer & Oncology Authors: Lucia Musacchio, Anna Amela Valsecchi, Vanda Salutari, Giorgio Valabrega, Floriana Camarda, Valentina Tuninetti, Gaia Giannone, Michele Bartoletti, Claudia Marchetti, Sandro Pignata, Anna Fagotti, Giovanni Scambia, Massimo Di Maio, Domenica Lorusso Tags: Anti-tumour Treatment Source Type: research